(Q34196128)

31 July 2017

1 reference

title

Oral anticoagulants. Pharmacologic issues for use in the elderly (English)

1 reference

31 July 2017

1 reference

1 reference

Hylek EM

1

1 reference

31 July 2017

language of work or name

1 reference

1 February 2001

1 reference

Clinics in geriatric medicine

31 July 2017

published in

1 reference

31 July 2017

volume

17

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

1-13

1 reference

Warfarin use among patients with atrial fibrillation

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Regional attitudes of generalists, specialists, and subspecialists about management of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Prospective evaluation of a flexible protocol for starting treatment with warfarin and predicting its maintenance dose

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Hepatic drug metabolism and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Flexible induction dose regimen for warfarin and prediction of maintenance dose

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Clinically significant drug interactions with the oral anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Aging and the anticoagulant response to warfarin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Hypothesized interaction between valproic acid and warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Carbamazepine-induced acceleration of diphenylhydantoin and warfarin metabolism in man

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Risk factors for intracranial hemorrhage in outpatients taking warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Enhanced elimination of warfarin during treatment with cholestyramine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Factors affecting the maintenance dose of warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Drugs and the ageing liver

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Acute stroke with atrial fibrillation. The Copenhagen Stroke Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Risk assessment and anticoagulation for primary stroke prevention in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Interaction of chronic daily warfarin therapy and rifampin

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

The stereoselective interaction of warfarin and metronidazole in man

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Stereoselective interaction of trimethoprim-sulfamethoxazole with the separated enantiomorphs of racemic warfarin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Effect of Sodium Dextrothyroxine in Patients Receiving Anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

The effect of dietary vitamin K on warfarin-induced anticoagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Comparison of an age adjusted warfarin loading protocol with empirical dosing and Fennerty's protocol.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Pharmacokinetics and pharmacodynamics of warfarin at steady state

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Recent advances: the cytochrome P450 enzymes.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Temporal trends in the use of anticoagulants among older adults with atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Recent national patterns of warfarin use in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Geriatric Pharmacology: Basic and Clinical Considerations*

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

A study of the interaction of omeprazole and warfarin in anticoagulated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Aging and determinants of hepatic drug clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Plasma protein binding of drugs in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Interactions of warfarin with drugs and food

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

The effect of age on pathways of drug metabolism in human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

The effect of age upon liver volume and apparent liver blood flow in healthy man.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

Effect of ageing upon warfarin dose requirements: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2805%2970102-6

7 January 2021

10.1016/S0749-0690(05)70102-6

Identifiers

DOI

1 reference

31 July 2017

1 reference